Key result
AV node ablation optimizes dual-chamber pacing in HOCM by ensuring RV capture when drugs fail.
Why the study?
Dual chamber pacing is a new treatment for drug-resistant hypertrophic obstructive cardiomyopathy with normal AV conduction, but incomplete RV capture and short AV delay may limit efficacy, indicating a need for AV node ablation or modulation.
Does atrioventricular node ablation improve symptoms and left ventricular filling in patients with drug-resistant hypertrophic obstructive cardiomyopathy treated with dual chamber pacing?
Does atrioventricular node ablation improve symptoms and left ventricular filling in patients with drug-resistant hypertrophic obstructive cardiomyopathy treated with dual chamber pacing?
AV node ablation may be indicated to optimize pacemaker treatment in HOCM patients when drug-induced AV prolongation fails or atrial fibrillation occurs, ensuring complete right ventricular capture.
May support AV node ablation in select HOCM with incomplete DDD capture; leaves open need for randomized confirmation.
Dual chamber pacing is a new indication for the treatment of drug resistant hypertrophic obstructive cardiontyopathy (HOCM) in patients with normal atrioventricular (AV) conduction. In sinus rhythm, the efficacy of the treatment is mainly related to the ability to bypass the normal AV conduction system in order to obtain a complete and permanent right ventricular (RV) capture. This is achieved by programming short AV delays. On the other hand, patients with HOCM frequently have co‐existing left ventricular diastolic dysfunction, and the atrial contribution to left ventricular filling is critical. The lack of improvement, rarely encountered, is probably due to incomplete RV capture andlor to the deleterious effect of short AV delay. Instrumental AV node prolongation may he indicated in this situation. This procedure should be undertaken when previous drug‐induced AV prolongation has failed. In theory, AV node modulation (i.e., creating a I ± AV block) seems ideal. However, this technique remains difficult, with disappointing chronic results. Most authors hence perform “conventional” AV node ablation. Particular attention is taken in order to perform a proximal node ablation, resulting in a complete AV block with narrow QRS escape rhythm. The reported incidence of AV node prolongation ranges from 7.5%‐37.5%. The efficacy of the procedure on symptoms is explained by improved left ventricular filling and/or a further reduction in the systolic gradient evoked by complete RV capture. Another indication for AV node ablation in HOCM is the occurrence of atrial fibrillation, in order to restore adequate and permanent RV capture.
No takes yet. Share an insight, caveat, or question.
Sadoul et al. (1996) conducted a review in Hypertrophic Obstructive Cardiomyopathy (HOCM). Atrioventricular Node Ablation was evaluated. Atrioventricular node ablation optimizes dual chamber pacing in hypertrophic obstructive cardiomyopathy by ensuring complete right ventricular capture when drug-induced AV prolongation fails.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: